The results revealed that 670 of the 10429 patients included in TCGA had mutations in HYDIN (6.42%), Notably, the highest incidence of HYDIN mutations was found in melanoma patients, with a rate of 36.14% (159/438) (Figure 1A). Here, HYDIN is linked to melanoma.